§ 2004. Manufacturer fee
(a) Annually, each pharmaceutical manufacturer or labeler of prescription drugs that are paid for by the Department of Vermont Health Access for individuals participating in Medicaid, Dr. Dynasaur, or VPharm shall pay a fee to the Agency of Human Services. The fee shall be 1.75 percent of the previous calendar year’s prescription drug spending by the Department and shall be assessed based on manufacturer labeler codes as used in the Medicaid rebate program.
(b) Fees collected under this section shall fund collection and analysis of information on pharmaceutical marketing activities under 18 V.S.A. §§ 4632 and 4633; analysis of prescription drug data needed by the Office of the Attorney General for enforcement activities; the Vermont Prescription Monitoring System established in 18 V.S.A. chapter 84A; the evidence-based education program established in 18 V.S.A. chapter 91, subchapter 2; statewide unused prescription drug disposal initiatives; prevention of prescription drug misuse, abuse, and diversion; the Substance Misuse Prevention Oversight and Advisory Council established in 18 V.S.A. § 4803; treatment of substance use disorder; exploration of nonpharmacological approaches to pain management; a hospital antimicrobial program for the purpose of reducing hospital-acquired infections; the purchase and distribution of fentanyl testing strips; the purchase and distribution of naloxone to emergency medical services personnel; and any opioid-antagonist education, training, and distribution program operated by the Department of Health or its agents. The fees shall be collected in the Evidence-Based Education and Advertising Fund established in section 2004a of this title.
(c) The Secretary of Human Services or designee shall make rules for the implementation of this section.
(d) The Department shall maintain on its website a list of the manufacturers who have failed to provide timely payment as required under this section. (Added 2007, No. 80, § 20; amended 2007, No. 89 (Adj. Sess.), § 4; 2009, No. 156 (Adj. Sess.), § I.67; 2011, No. 162 (Adj. Sess.), § E.311; 2013, No. 50, § E.312.1; 2013, No. 79, § 27, eff. Jan. 1, 2014; 2013, No. 95 (Adj. Sess.), § 84, eff. Feb. 25, 2014; 2015, No. 173 (Adj. Sess.), § 12, eff. Jan. 1, 2016; 2019, No. 70, § 29; 2019, No. 72, § E.313.)
Structure Vermont Statutes
Chapter 19 - Medical Assistance
§ 1901. Administration of program
§ 1901b. Pharmacy program enrollment
§ 1901d. State Health Care Resources Fund
§ 1901e. Global Commitment Fund
§ 1901f. Medicaid program enrollment and expenditure reports
§ 1901g. Medicaid coverage for home telemonitoring services
§ 1901j. Medicaid reimbursement for long-acting reversible contraceptives
§ 1901k. Medicaid coverage for hearing aids and audiology services
§ 1902. Qualification for medical assistance
§ 1903a. Care management program
§ 1905. Disproportionate share program
§ 1905a. Medicaid reimbursements to certain outpatient providers
§ 1906. Recoupment of amounts spent on child medical care
§ 1906a. Recovery against estate; homestead exemptions
§ 1908. Medicaid; payer of last resort; release of information
§ 1908a. Vermont Partnership for Long-Term Care
§ 1909. Direct payments to Agency; discharge of insurer’s obligation
§ 1910. Liability of third parties; liens
§ 1911. Tobacco manufacturers; liability for Medicaid expenditures
§ 1918. Directory of cigarettes approved for stamping and sale
§ 1919. Prohibition against the stamping and sale of cigarettes not included in the directory
§ 1920. Agent for service of process
§ 1921. Reporting and sharing of information
§ 1922. Quarterly escrow deposits
§ 1923. Penalties and other remedies
§ 1924. Miscellaneous provisions
§ 1925. Joint and several liability of importers on nonparticipating manufacturer’s brand families
§ 1954. Nursing home assessment
§ 1955a. Home health agency assessment
§ 1956. Proceeds from assessments
§ 1959. Ambulance agency assessment
§ 1992. Medicaid coverage for adult dental services
§ 1998. Pharmacy Best Practices and Cost Control Program established
§ 1999. Consumer protection rules; prior authorization
§ 2000. Pharmacy benefit management
§ 2003. Pharmacy discount plans
§ 2004a. Evidence-Based Education and Advertising Fund
§ 2007. Canadian Prescription Drug Information Program
§ 2031. Creation of Clinical Utilization Review Board
§ 2032. Role of Department of Vermont Health Access
§ 2073. VPharm assistance program
§ 2075. Assistance in enrolling in Medicare Part D
§ 2076. Over-the-counter and generic medications
§ 2078. Education and outreach
§ 2080. Vermont Prescription Drug Pricing and Consumer Protection Program
§ 2091. Dr. Dynasaur-like coverage; legislative intent
§ 2092. Dr. Dynasaur-like coverage for certain Vermont residents